Novo Nordisk Files Lawsuit Against Eli Lilly Over Weight-Loss Drug Advertisements
Novo Nordisk has filed a lawsuit against Eli Lilly, seeking an injunction to block the latter's advertisements for its weight-loss and diabetes drugs. The Danish company claims that Lilly’s ads mislead consumers by comparing outdated data and lower doses of Novo's products with higher doses from Lilly. Both companies are competing in a projected $100 billion U.S. obesity drug market.
